Trials / Completed
CompletedNCT05121415
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
Preventive and Personalized Medicine (2021-2023)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Asfendiyarov Kazakh National Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- —
Summary
To search for a genetic marker of hemorrhagic stroke complicating severe eclampsia, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with hemorrhagic stroke and normal control will be performed.
Detailed description
Detailed Description: Unrelated Korean subjects who have Spontaneous hemorrhagic stroke complicating severe eclampsia in pregnancy were recruited in the current study. Genotyping for various SNP associated due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with hemorrhagic stroke and normal control subjects free of hemorrhagic stroke
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | SNP analysis of the DNA | SNP analysis of the DNA obtained from peripheral blood sample |
Timeline
- Start date
- 2021-10-23
- Primary completion
- 2023-01-20
- Completion
- 2023-01-20
- First posted
- 2021-11-16
- Last updated
- 2023-03-14
Locations
1 site across 1 country: Kazakhstan
Source: ClinicalTrials.gov record NCT05121415. Inclusion in this directory is not an endorsement.